Skip to main content

Day: September 29, 2022

New Strategic and Modern Facilities for Colabor Group

BOUCHERVILLE, Quebec, Sept. 29, 2022 (GLOBE NEWSWIRE) — Colabor Group Inc. (TSX : GCL) (“Colabor” or the “Company”), a leading distributor of food and related products serving the Quebec and Atlantic Canada markets, announces today that, by the end of 2023, it will be moving its Boucherville head office and warehouse to new facilities in the Saint-Bruno-de-Montarville Industrial Ecopark, near its current location. The new industrial premises will be more modern, better located for operations, and will offer a stimulating work environment, ideal for the well-being of employees. “Colabor has been in business for over 60 years. Today’s announcement marks the beginning of a new chapter in our history as we set out to accelerate the implementation of our strategic plan,” said Louis Frenette, President and CEO of Colabor....

Continue reading

EMM Loans Partners with SimpleNexus to Drive Operational Efficiency and Boost Loan Revenue

New Jersey-based lender prepares company-wide launch of Nexus Origination to enhance its customer-focused mortgage experience and award-winning internal culture LEHI, Utah, Sept. 29, 2022 (GLOBE NEWSWIRE) — SimpleNexus (https://simplenexus.com/), an nCino (NASDAQ: NCNO) company and developer of the leading U.S. homeownership platform for loan officers, borrowers, real estate agents and settlement agents, announced today that EMM Loans has chosen SimpleNexus’ Nexus Engagement™ and Nexus Origination™ to power an electronic mortgage experience, attract and retain top talent and garner more business for its retail, wholesale, correspondent and consumer direct lending channels. Founded in 2004, EMM Loans is a New Jersey-based lender offering private, direct and affordable mortgage loans. With 91 loan officers licensed in 38 states,...

Continue reading

Cognition Therapeutics to Participate in the 2022 Cantor Fitzgerald Neurology & Psychiatry Conference

PURCHASE, N.Y., Sept. 29, 2022 (GLOBE NEWSWIRE) — Cognition Therapeutics, Inc. (Nasdaq: CGTX) (the “Company” or “Cognition”), a clinical-stage biopharmaceutical company engaged in the discovery and development of innovative, small molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina, announced today that the Company’s president and CEO, Lisa Ricciardi will participate in a panel discussion and host one-on-one meetings at the Cantor Fitzgerald Neurology & Psychiatry Conference taking place in San Francisco from October 6-7, 2022. Details of Cognition’s participation in the conference are as follows: Event: Cantor Fitzgerald Neurology & Psychiatry Conference Panel Title: Wave of Innovation for Alzheimer’s Disease – Small & Large Molecule Approaches...

Continue reading

SIGA Technologies Announces New Contract Awarded by U.S. Department of Defense for the Procurement of up to $10.7 Million of Oral TPOXX®

– In 2022, the U.S. Department of Defense has Awarded Procurement Contracts for the Purchase of up to $18.1 Million of Oral TPOXX – NEW YORK, Sept. 29, 2022 (GLOBE NEWSWIRE) — SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced that the U.S. Department of Defense (DoD) awarded a new contract to SIGA for the procurement of up to $10.7 million of oral TPOXX (Contract number: W911SR22C0051), of which $5.1 million of oral TPOXX is targeted for delivery in 2022 and the remainder is subject to an option at the sole discretion of the DoD. This contract follows an award made earlier this year for the procurement of $7.4 million of oral TPOXX (Contract number: W911SR22C0032), under which all product is expected to be delivered in 2022.    SIGA...

Continue reading

GBT is researching the Development of Electro-Thermal Aware Design Environment for Integrated Circuits

Seeking to Address Advanced Nanometer Nodes Semiconductors Electro-Thermal Modeling and Optimization SAN DIEGO, Sept. 29, 2022 (GLOBE NEWSWIRE) — GBT Technologies Inc. (OTC PINK: GTCHD) (“GBT” or the “Company”) is researching to develop Electro-Thermal Aware design environment electronic design automation (EDA) technology for integrated circuits (IC). Increasing power densities, cost and an associated greater utilization of advanced nodes semiconductors are making electro-thermal analysis and simulation a crucial reliability aspect. The ever-growing packing density and power consumption factors are significantly affecting IC’s design’s electro-thermal behavior. The increasing variability of processes parameters, particularly in advanced nanometer technologies has resulted in a larger impact of the substrate and metal line...

Continue reading

Constantine and American Pacific Mining Announce Mailing of Meeting Materials in Connection with Constantine’s Special Meeting to Approve Acquisition by American Pacific Mining

VANCOUVER, British Columbia, Sept. 29, 2022 (GLOBE NEWSWIRE) — American Pacific Mining Corp (CSE: USGD / FWB: 1QC / OTCQX: USGDF) (“American Pacific” or “APM”) and Constantine Metal Resources Ltd. (“Constantine”) (TSXV: CEM) (OTCQX: CNSNF) are pleased to announce Constantine has mailed and filed a management information circular dated September 22, 2022 (the “Circular”) and related meeting materials (collectively, the “Meeting Materials”) for its special meeting (the “Meeting”) of Securityholders (as defined below) to be held October 25, 2022, in connection with the proposed acquisition of all of the outstanding shares of Constantine (“Constantine Shares”) by American Pacific announced on August 15, 2022 (the “Transaction” or the “Arrangement”). The Meeting will be held at the offices of Blake, Cassels & Graydon LLP, 595 Burrard...

Continue reading

SL Green Inks 347,000 Square Foot Lease with Franklin Templeton at One Madison Avenue

NEW YORK, Sept. 29, 2022 (GLOBE NEWSWIRE) — SL Green Realty Corp. (NYSE: SLG), Manhattan’s largest office landlord, today announced that investment management firm Franklin Templeton has signed a 15-year, 347,474 square foot lease at One Madison Avenue. The company will occupy the entire 11th through 22nd floors in the tower portion of the building. This lease follows the recently announced 328,000 square foot lease with International Business Machines Corporation (“IBM”) and the 56,000 square foot lease with Chelsea Piers Fitness. The neighborhood defining development, which is on schedule for completion in November 2023, is now 55% leased. “We’re excited to welcome Franklin Templeton to One Madison Avenue,” said Marc Holliday, Chairman and CEO of SL Green. “This lease and the earlier IBM transaction are the second and third largest...

Continue reading

VitalHub Announces Multi Year Contract With Stevenson Memorial Hospital and Georgian Bay General Hospital

TORONTO, Sept. 29, 2022 (GLOBE NEWSWIRE) — VitalHub Corp. (the “Company” or “VitalHub”) (TSXV: VHI) (OTCQX:VHIBF) is pleased to announce two new licensing agreements of it’s prEDict solution to Stevenson Memorial Hospital (“SMH”) and Georgian Bay General Hospital (“GBGH”), both in Ontario. Stevenson Memorial Hospital (Alliston) has signed a 5-year term and Georgian Bay General Hospital (Midland) has signed a 3-year term, with two optional 1-year extension periods. prEDict is an emergency department (ED) wait time clock, that accurately broadcasts wait times to the community via the hospital website. This unprecedented period in healthcare is currently being made more complicated by staffing issues and higher acuity patients. With emergency departments across the country under significant and severe pressure, communicating ED wait...

Continue reading

Victory Square’s Subsidiary, Draft Label Technologies, Enters Into Definitive Agreement to Complete Business Combination Transaction

/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/ VANCOUVER, British Columbia, Sept. 29, 2022 (GLOBE NEWSWIRE) — Victory Square Technologies Inc. (CSE:VST) (OTC:VSQTF) (“VST” or the “Company”) is pleased to announce that further to the letter of intent entered into on June 23, 2022 (the “LOI”) with 1288273 B.C. Ltd. (“AcquisitionCo“) and Draft Label Technologies Inc. (“Draft Label”), a wholly-owned subsidiary of the Company, the Company has entered into a share exchange agreement effective on September 28, 2022, with AcquisitionCo and Draft Label (the “Share Exchange Agreement”), in respect of a business combination pursuant to which AcquisitionCo will acquire all of the equity interests of Draft Label and the shareholders of Draft Label will receive shares of AcquisitionCo...

Continue reading

InflaRx Submits Request for Emergency Use Authorization to US FDA for Vilobelimab for Treatment of Critically Ill COVID-19 Patients

Company also earns FDA Fast Track designation for vilobelimab to treat critically ill COVID-19 patients EUA submission based on Phase III results in critically ill COVID-19 patients, recently published in The Lancet Respiratory Medicine Request for EUA follows encouraging interactions with FDA in Type B meeting “Gohibic” conditionally accepted by FDA as proprietary name for vilobelimabJENA, Germany, Sept. 29, 2022 (GLOBE NEWSWIRE) — InflaRx N.V. (Nasdaq: IFRX), a clinical-stage biopharmaceutical company developing anti-inflammatory therapeutics by targeting the complement system, today submitted a request for Emergency Use Authorization (EUA) following encouraging interactions with the US Food and Drug Administration (FDA) at a Type B meeting held this summer. Additionally, InflaRx has been granted Fast Track designation from...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.